A. Hamdan, V. Guetta, R. Klempfner, E. Konen, E. Raanani et al., Inverse Relationship between Membranous Septal Length and the Risk of Atrioventricular Block in Patients Undergoing Transcatheter Aortic Valve Implantation, JACC Cardiovasc Interv, vol.8, pp.1218-1246, 2015.

J. L. Arcy, B. D. Prendergast, J. B. Chambers, S. G. Ray, and B. Bridgewater, Valvular heart disease: the next cardiac epidemic, Heart, vol.97, pp.91-94, 2011.

J. L. Arcy, S. Coffey, M. A. Loudon, A. Kennedy, J. Pearson-stuttard et al., Largescale community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people: the OxVALVE Population Cohort Study, Eur Heart J, vol.37, pp.3515-3537, 2016.

R. Osnabrugge, D. Mylotte, S. J. Head, N. M. Van-mieghem, V. T. Nkomo et al., Aortic stenosis in the elderly: Disease prevalence and number of candidates for transcatheter aortic valve replacement: A meta-analysis and modeling study, J Am Coll Cardiol, vol.62, pp.1002-1014, 2013.

B. Iung, G. Baron, E. G. Butchart, F. Delahaye, C. Gohlke-bärwolf et al., A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease, Eur Heart J, vol.24, pp.1231-1274, 2003.

G. W. Eveborn, H. Schirmer, G. Heggelund, P. Lunde, and K. Rasmussen, The evolving epidemiology of valvular aortic stenosis. the Tromsø study, Heart, vol.99, pp.396-400, 2013.

V. T. Nkomo, J. M. Gardin, T. N. Skelton, J. S. Gottdiener, C. G. Scott et al., Burden of valvular heart diseases: a population-based study, Lancet, vol.368, pp.69208-69216, 2006.

S. R. Kapadia, M. B. Leon, R. R. Makkar, E. M. Tuzcu, L. G. Svensson et al., 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial, Lancet, vol.385, pp.2485-91, 2015.

D. Horstkotte and F. Loogen, The natural history of aortic valve stenosis, Eur Heart J, vol.9, pp.57-64, 1988.

A. M. Matthews, The development of the Starr-Edwards heart valve, Texas Hear Inst J, vol.25, pp.282-93, 1998.

J. P. Binet, A. Carpentier, J. Langlois, C. Duran, and P. Colvez,

, C R Acad Sci Hebd Seances Acad Sci D, vol.261, pp.5733-5737, 1965.

J. P. Binet, A. Carpentier, and J. Langlois, Clinical use of heterografts for replacement of the aortic valve, J Thorac Cardiovasc Surg, vol.55, pp.238-280, 1968.

A. Cribier, N. Saoudi, J. Berland, T. Savin, P. Rocha et al., PERCUTANEOUS TRANSLUMINAL VALVULOPLASTY OF ACQUIRED AORTIC STENOSIS IN ELDERLY PATIENTS: AN ALTERNATIVE TO VALVE REPLACEMENT?, Lancet, vol.327, issue.86, pp.90716-90722, 1986.

A. Cribier, H. Eltchaninoff, A. Bash, N. Borenstein, C. Tron et al., Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description, Circulation, vol.106, pp.3006-3014, 2002.

A. Cribier, H. Eltchaninoff, C. Tron, F. Bauer, C. Agatiello et al., Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis, J Am Coll Cardiol, vol.43, pp.698-703, 2004.

M. B. Leon, C. R. Smith, M. Mack, D. C. Miller, J. W. Moses et al., Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery, N Engl J Med, vol.363, pp.1597-607, 2010.

R. R. Makkar, G. P. Fontana, H. Jilaihawi, S. Kapadia, A. D. Pichard et al., Transcatheter aortic-valve replacement for inoperable severe aortic stenosis, N Engl J Med, vol.366, pp.1696-704, 2012.

A. Vahanian, O. Alfieri, F. Andreotti, M. J. Antunes, G. Barón-esquivias et al., Guidelines on the management of valvular heart disease (version 2012), Eur Heart J, vol.33, pp.2451-96, 2012.

R. A. Nishimura, C. M. Otto, R. O. Bonow, B. A. Carabello, J. P. Erwin et al., , 2014.

, AHA/ACC guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, J Thorac Cardiovasc Surg, vol.148, pp.1-132, 2014.

M. Barbanti, A. S. Petronio, F. Ettori, A. Latib, F. Bedogni et al., 5-Year Outcomes after Transcatheter Aortic Valve Implantation with CoreValve Prosthesis, JACC Cardiovasc Interv, vol.8, pp.1084-91, 2015.

M. J. Mack, M. B. Leon, C. R. Smith, D. C. Miller, J. W. Moses et al., 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial, Lancet, vol.385, pp.60308-60315, 2015.

M. B. Leon, C. R. Smith, M. J. Mack, R. R. Makkar, L. G. Svensson et al., Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients, N Engl J Med, vol.374, 2016.

M. J. Reardon, N. M. Van-mieghem, J. J. Popma, N. S. Kleiman, L. Søndergaard et al., Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients, N Engl J Med, vol.376, pp.1321-1352, 2017.

V. H. Thourani, S. Kodali, R. R. Makkar, H. C. Herrmann, M. Williams et al., Transcatheter aortic valve replacement versus surgical valve replacement in intermediaterisk patients: a propensity score analysis, Lancet, vol.387, issue.16, pp.30073-30076, 2016.

R. A. Nishimura, C. M. Otto, R. O. Bonow, B. A. Carabello, J. P. Erwin et al., AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients with Valvular Heart Disease: A Report of the American College of Cardiology, American Heart Association Task Force on Clinical Practice Guidelines, vol.135, 2017.

H. Baumgartner, V. Falk, J. J. Bax, D. Bonis, M. Hamm et al., ESC/EACTS Guidelines for the management of valvular heart diseaseThe Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), Eur Heart J n, 2017.

, The PARTNER 3 -Trial -The Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis -Full Text ViewClinicalTrials

J. Popma and M. J. Reardon, Medtronic Transcatheter Aortic Valve Replacement in Low Risk Patients

, Comparison of Transcatheter Versus Surgical Aortic Valve Replacement in Younger Low Surgical Risk Patients With Severe Aortic Stenosis -Tabular View -ClinicalTrials

J. Seeger, B. Gonska, W. Rottbauer, and J. Wöhrle, New generation devices for transfemoral transcatheter aortic valve replacement are superior compared with last generation devices with respect to VARC-2 outcome, Cardiovasc Interv Ther, vol.33, pp.247-55, 2018.

M. Urena, J. G. Webb, C. Tamburino, A. J. Muñoz-garcía, A. Cheema et al., Permanent pacemaker implantation after transcatheter aortic valve implantation impact on late clinical outcomes and left ventricular function, Circulation, vol.129, pp.1233-1276, 2014.

A. Mehilli, J. Frerker, C. Neumann, F. Kurz, T. Tölg et al., Comparison of Balloon-Expandable vs Self-expandable Valves in Patients Undergoing Transcatheter Aortic Valve Replacement, JAMA, vol.311, p.1503, 2014.

C. Chamandi, M. Barbanti, A. Munoz-garcia, A. Latib, L. Nombela-franco et al., Long-Term Outcomes in Patients With New Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement, JACC Cardiovasc Interv, vol.11, pp.287-97, 2018.

T. M. Nazif, J. M. Dizon, R. T. Hahn, K. Xu, V. Babaliaros et al., Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: The PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry, JACC Cardiovasc Interv, vol.8, pp.60-69, 2015.

I. G. Matthews, I. A. Fazal, M. Bates, and A. J. Turley, In patients undergoing aortic valve replacement, what factors predict the requirement for permanent pacemaker implantation?, Interact Cardiovasc Thorac Surg, vol.12, pp.475-484, 2011.

G. Siontis, P. Jüni, T. Pilgrim, S. Stortecky, L. Büllesfeld et al., Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVR: A meta-analysis, J Am Coll Cardiol, vol.64, pp.129-169, 2014.

V. Mauri, A. Reimann, D. Stern, M. Scherner, E. Kuhn et al., Predictors of Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement With the SAPIEN 3, JACC Cardiovasc Interv, vol.9, pp.2200-2209, 2016.

I. Sutton, Y. Jp, S. Ho, and R. H. Anderson, The Forgotten Interleaflet Triangles: A Review of the Surgical Anatomy of the Aortic Valve, vol.59, 1995.

N. Piazza, P. De-jaegere, C. Schultz, A. E. Becker, P. W. Serruys et al., Anatomy of the Aortic Valvar Complex and Its Implications for Transcatheter Implantation of the Aortic Valve, Circ Cardiovasc Interv, vol.1, pp.74-81, 2008.

S. Tawara, Das Reizleitungssystem des Saeugetierherzens, 1906.

R. Moreno, D. Dobarro, L. De-sá, E. Prieto, M. Morales et al., Cause of complete atrioventricular block after percutaneous aortic valve implantation: Insights from a necropsy study, Circulation, vol.120, pp.29-30, 2009.

Y. Maeno, Y. Abramowitz, H. Kawamori, Y. Kazuno, S. Kubo et al., A Highly Predictive Risk Model for Pacemaker Implantation After TAVR, JACC Cardiovasc Imaging, vol.10, pp.1139-1186, 2017.

S. Abbara, P. Blanke, C. D. Maroules, M. Cheezum, A. D. Choi et al., SCCT guidelines for the performance and acquisition of coronary computed tomographic angiography: A report of the society of Cardiovascular Computed Tomography Guidelines Committee: Endorsed by the North American Society for Cardiovascular Imaging (NASCI), J Cardiovasc Comput Tomogr, vol.10, pp.435-484, 2016.

S. Achenbach, V. Delgado, J. Hausleiter, P. Schoenhagen, J. K. Min et al., SCCT expert consensus document on computed tomography imaging before transcatheter aortic valve implantation (TAVI)/transcatheter aortic valve replacement (TAVR), J Cardiovasc Comput Tomogr, vol.6, pp.366-80, 2012.

P. Paul, M. L. Pennell, and S. Lemeshow, Standardizing the power of the Hosmer-Lemeshow goodness of fit test in large data sets, Stat Med, vol.32, pp.67-80, 2013.

E. R. Delong, D. M. Delong, and D. L. Clarke-pearson, Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach, Biometrics, vol.44, pp.837-882, 1988.

A. P. Kappetein, S. J. Head, P. Généreux, N. Piazza, N. M. Van-mieghem et al., Updated Standardized Endpoint Definitions for Transcatheter Aortic Valve Implantation, J Am Coll Cardiol, vol.60, pp.1438-54, 2012.

B. A. Oestreich, M. Mbai, S. Gurevich, P. S. Nijjar, S. Adabag et al., Computed tomography (CT) assessment of the membranous septal anatomy prior to transcatheter aortic valve replacement (TAVR) with the balloon-expandable SAPIEN 3 valve, Cardiovasc Revascularization Med, 2018.

O. O. Fadahunsi, A. Olowoyeye, A. Ukaigwe, Z. Li, A. N. Vora et al., Predictors, and Outcomes of Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement: Analysis From the U.S. Society of Thoracic Surgeons/American College of Cardiology TVT Registry, JACC Cardiovasc Interv, vol.9, pp.2189-99, 2016.

T. R. Kambur, M. Das, and R. Agarwal, The natural history of symptomatic cardiac conductionsystem disease in end-stage renal disease, Nephrol Dial Transplant, vol.31, pp.1973-1978, 2016.

M. Y. Lee, S. C. Yeshwant, S. Chava, and D. L. Lustgarten, Mechanisms of Heart Block after Transcatheter Aortic Valve Replacement -Cardiac Anatomy, Clinical Predictors and Mechanical Factors that Contribute to Permanent Pacemaker Implantation, Arrhythmia Electrophysiol Rev, vol.04, p.81, 2015.

L. A. Mcguinness, J. Higgins, and J. Sterne, Assessing the Credibility of Findings From Nonrandomized Studies of Interventions, JAMA Cardiol, 2018.

M. Brignole, A. Auricchio, G. Baron-esquivias, P. Bordachar, G. Boriani et al., ESC Guidelines on cardiac pacing and cardiac resynchronization therapy, Europace, vol.15, pp.1070-118, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00879501

V. Ribeiro, M. Garcia, R. Frutuoso, C. Melão, F. Pereira et al., Permanent pacemaker implantation after aortic valve replacement: Long-term dependency or rhythm recovery?, Rev Port Cardiol, vol.34, pp.529-562, 2015.

C. Chamandi, M. Barbanti, A. Munoz-garcia, A. Latib, L. Nombela-franco et al., Long-Term Outcomes in Patients With New Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement, JACC Cardiovasc Interv, 2018.

G. S. Bloomfield, L. D. Gillam, R. T. Hahn, S. Kapadia, J. Leipsic et al., A practical guide to multimodality imaging of transcatheter aortic valve replacement, JACC Cardiovasc Imaging, vol.5, pp.441-55, 2012.

, Au moment d'être admis à exercer la médecine, je promets et je jure d'être fidèle aux lois de l'honneur et de la probité

, Mon premier souci sera de rétablir, de préserver ou de promouvoir la santé dans tous ses éléments, physiques et mentaux

, Je respecterai toutes les personnes, leur autonomie et leur volonté, sans aucune discrimination selon leur état ou leurs convictions. J'interviendrai pour les protéger si elles sont affaiblies, vulnérables ou menacées dans leur intégrité ou leur dignité. Même sous la contrainte

, Je ne tromperai jamais leur confiance et n'exploiterai pas le pouvoir hérité des circonstances pour forcer les consciences

, Admis dans l'intimité des personnes, je tairai les secrets qui me seront confiés. Reçue à l'intérieur des maisons, je respecterai les secrets des foyers et ma conduite ne servira pas à corrompre les moeurs

, Je ferai tout pour soulager les souffrances. Je ne prolongerai pas abusivement les agonies. Je ne provoquerai jamais la mort délibérément

, Je n'entreprendrai rien qui dépasse mes compétences. Je les entretiendrai et les perfectionnerai pour assurer au mieux les services qui me seront demandés

, J'apporterai mon aide à mes confrères ainsi qu'à leurs familles dans l'adversité

, Que les hommes et mes confrères m'accordent leur estime si je suis fidèle à mes promesses ; que je sois déshonoré et méprisé si j'y manque